Leveraging AI to Identify Cellular Senescence Heterogeneity Across AgeRelated Diseases for therapeutic Interventions
Time: 10:00 am
day: Conference Day Two
Details:
- Senolytics are a powerful therapeutic opportunity to treat age-related chronic conditions
- An analogy with cancer cells: Cellular senescence is pleiotropic and characterised by a high degree of heterogeneity
- Not all states of cellular senescence are relevant therapeutic targets
- Introducing Alembic: AI computational single-cell multi-omics platform developed to elucidate the heterogeneity between cell types and cell states for novel first-in-class drug discovery
